aTyr Pharma reported $190K in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Ardelyx USD 114.37M 8.02M Dec/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Biogen USD 1.82B 169.5M Mar/2026
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Cipla INR 39.1B 2.54B Mar/2026
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 63.8M 63.56M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Curis USD 1.14M 8.86M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Grifols EUR 766.49M 39.74M Dec/2024
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
United Therapeutics USD 315.5M 286.6M Dec/2025
Xoma 992K 846K Jun/2024